Ignite Creation Date:
2025-12-24 @ 2:54 PM
Ignite Modification Date:
2026-02-02 @ 1:39 AM
Study NCT ID:
NCT05468359
Status:
SUSPENDED
Last Update Posted:
2025-05-25
First Post:
2022-06-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
Sponsor:
St. Jude Children's Research Hospital
Organization: